A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a ...
Hosted on MSN2d
Nanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other CoronavirusesA newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...
RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...
Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...
After a brief moment when Americans came together to battle a virus, the pandemic accelerated divisions of all kinds. If it ...
The Executive Council blocked a $25,000 contract until Dartmouth Health proved to state prosecutors that it's complying with the Patient Bill of Rights and not denying treatment based on someone's ...
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback